Assets, Current in USD of Mosaic ImmunoEngineering Inc. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Mosaic ImmunoEngineering Inc. quarterly Assets, Current history and change rate from Q2 2011 to Q3 2025.
  • Mosaic ImmunoEngineering Inc. Assets, Current for the quarter ending 30 Sep 2025 was $55.3K, a 38.4% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $55.3K +$15.3K +38.4% 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 $57.7K +$45.4K +370% 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 $97.8K +$18.8K +23.9% 31 Mar 2025 10-Q 20 May 2025
Q4 2024 $142K -$37.9K -21.1% 31 Dec 2024 10-Q 19 Nov 2025
Q3 2024 $40K -$246K -86% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $12.3K -$357K -96.7% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $79K -$69.5K -46.8% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $180K -$81.7K -31.3% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $286K -$147K -34% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $369K +$146K +65.5% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $148K -$255K -63.2% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $261K -$8.22K -3.05% 31 Dec 2022 10-K 15 Apr 2024
Q3 2022 $433K -$12.7K -2.86% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $223K -$379K -63% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $404K +$136K +50.9% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $269K -$188K -41.1% 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $446K -$171K -27.7% 30 Sep 2021 10-Q 02 Nov 2021
Q2 2021 $602K +$602K 30 Jun 2021 10-Q 03 Aug 2021
Q1 2021 $268K -$742K -73.5% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $458K -$789K -63.3% 31 Dec 2020 10-K 26 Jan 2022
Q3 2020 $617K -$885K -58.9% 31 Aug 2020 10-Q 15 Oct 2020
Q2 2020 $563* -$1.79M 31 May 2020 10-KT 02 Mar 2021
Q1 2020 $1.01M -$981K -49.3% 29 Feb 2020 10-Q 08 Apr 2020
Q4 2019 $1.25M -$702K -36% 30 Nov 2019 10-Q 14 Jan 2020
Q3 2019 $1.5M -$621K -29.2% 31 Aug 2019 10-Q 11 Oct 2019
Q2 2019 $1.79M -$537K -23.1% 31 May 2019 10-K 24 Aug 2020
Q1 2019 $1.99M -$581K -22.6% 28 Feb 2019 10-Q 15 Apr 2019
Q4 2018 $1.95M -$837K -30.1% 30 Nov 2018 10-Q 14 Jan 2019
Q3 2018 $2.12M -$946K -30.8% 31 Aug 2018 10-Q 15 Oct 2018
Q2 2018 $2.33M -$990K -29.9% 31 May 2018 10-K 29 Aug 2019
Q1 2018 $2.57M -$819K -24.2% 28 Feb 2018 10-Q 16 Apr 2018
Q4 2017 $2.79M -$626K -18.4% 30 Nov 2017 10-Q 16 Jan 2018
Q3 2017 $3.07M +$230K +8.09% 31 Aug 2017 10-Q 16 Oct 2017
Q2 2017 $3.32M +$165K +5.22% 31 May 2017 10-K 29 Aug 2018
Q1 2017 $3.39M -$432K -11.3% 28 Feb 2017 10-Q 13 Apr 2017
Q4 2016 $3.41M -$811K -19.2% 30 Nov 2016 10-Q 17 Jan 2017
Q3 2016 $2.84M -$1.95M -40.7% 31 Aug 2016 10-Q 17 Oct 2016
Q2 2016 $3.15M -$2.02M -39.1% 31 May 2016 10-K 29 Aug 2017
Q1 2016 $3.82M -$1.74M -31.3% 29 Feb 2016 10-Q 14 Apr 2016
Q4 2015 $4.22M -$1.55M -26.8% 30 Nov 2015 10-Q 14 Jan 2016
Q3 2015 $4.79M -$1.35M -22% 31 Aug 2015 10-Q 15 Oct 2015
Q2 2015 $5.18M -$1.52M -22.7% 31 May 2015 10-K 29 Aug 2016
Q1 2015 $5.57M -$1.47M -20.9% 28 Feb 2015 10-Q 14 Apr 2015
Q4 2014 $5.77M -$1.7M -22.8% 30 Nov 2014 10-Q 14 Jan 2015
Q3 2014 $6.14M -$1.39M -18.4% 31 Aug 2014 10-Q 15 Oct 2014
Q2 2014 $6.7M -$1.34M -16.7% 31 May 2014 10-K 31 Aug 2015
Q1 2014 $7.04M -$288K -3.93% 28 Feb 2014 10-Q 14 Apr 2014
Q4 2013 $7.47M +$318K +4.44% 30 Nov 2013 10-Q 14 Jan 2014
Q3 2013 $7.53M +$794K +11.8% 31 Aug 2013 10-Q 15 Oct 2013
Q2 2013 $8.04M +$181K +2.3% 31 May 2013 10-K 19 Aug 2014
Q1 2013 $7.33M -$1.32M -15.2% 28 Feb 2013 10-Q 15 Apr 2013
Q4 2012 $7.15M -$2.65M -27.1% 30 Nov 2012 10-Q 14 Jan 2013
Q3 2012 $6.73M -$4.18M -38.3% 31 Aug 2012 10-Q 15 Oct 2012
Q2 2012 $7.86M -$4.34M -35.6% 31 May 2012 10-K 23 Aug 2013
Q1 2012 $8.64M 29 Feb 2012 10-Q 16 Apr 2012
Q4 2011 $9.81M 30 Nov 2011 10-Q 17 Jan 2012
Q3 2011 $10.9M 31 Aug 2011 10-Q 17 Oct 2011
Q2 2011 $12.2M 31 May 2011 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.